Results 101 to 110 of about 169 (166)
Fabrication process of phase change microcapsules using a Pickering emulsion template method and their subsequent applications. The increasing demand for efficient thermal energy storage systems has driven the development of phase change material microcapsules (PCMMs), which provide high energy‐storage density, reversible phase change, and reduced ...
Ziyan Li +4 more
wiley +1 more source
In this work, a novel biomolecule/semiconductor hybrid catalyst was prepared by loading anthraquinone‐liked juglone onto anatase TiO2. This catalyst exhibited high photocatalytic activity for H2O2 production. Hydrogen peroxide (H2O2) is a vital oxidant with broad industrial applications, and its production via photocatalysis represents a highly ...
Zengyin He +4 more
wiley +1 more source
Low‐dimensional materials (0D, 1D, and 2D) exhibit unique electronic and physicochemical properties, enabling advanced nanoelectronic and optoelectronic devices. Mixed‐dimensional heterostructures combine these materials to enhance functionality.
Qaisar Alam +3 more
wiley +1 more source
This work reports one‐pot synthesized novel zwitterionic polydopamine‐silica (ZSiPDA) nanofillers for fabricating PES hybrid ultrafiltration membranes with enhanced hydrophilicity, permeability, and antifouling performance. The optimized membrane achieved over 91% humic acid removal and showed strong potential for municipal wastewater treatment.
Roqaya A. Ismail +5 more
wiley +1 more source
Gut‐microbiota‐brain Axis and post‐traumatic epilepsy
Abstract There has been growing evidence that perturbations in gut‐microbiota‐brain axis (GMBA) are involved in mechanisms of chronic sequelae of traumatic brain injury (TBI). This review discusses the connection between GMBA and post‐traumatic epilepsy (PTE), the latter being a common outcome of TBI.
Andrey Mazarati
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Corticosteroids, dopamine antagonists and other drugs
Supportive Care in Cancer, 1998The literature on corticosteroids, dopamine antagonists and other antiemetics, such as cannabinoids and benzodiazepines. was reviewed and presented at a consensus conference on antiemetics. Based on the reviews and the discussion during the conference, guidelines for the use of these agents are given.
Jørn Herrstedt +2 more
exaly +3 more sources
Use of Dopamine Antagonists in Treatment of Migraine
Current Treatment Options in Neurology, 2011Dopamine antagonists are indicated for treatment of nausea or psychosis and have an established role in the treatment of migraine. Neuroleptics, including antipsychotics, act as antagonists at the dopamine D2 receptor type. These medications also have variable activity as antihistamines and anticholinergics, and they block alpha-adrenergic and some ...
Michael J Marmura, Marmura Michael J
exaly +3 more sources
Is Bromocriptine a Dopamine Antagonist Treatment?
Archives of General Psychiatry, 1983To the Editor. — We would like to elaborate on one point of the excellent article "Therapeutic Strategies Against Tardive Dyskinesia" by Jeste and Wyatt (Archives1982;39:803-816). The authors classified bromocriptine mesylate as a treatment of dopamine (DA) antagonism, ie, decreasing DA neurotransmission.
J, Lieberman, M, Lesser, R, Brenner
openaire +2 more sources
Reversal of respiratory responses to dopamine after dopamine antagonists
Respiration Physiology, 1982The effects of dopamine (DA) antagonists upon resting ventilation and ventilatory reactions to DA, apomorphine, hyperoxia and hypoxia were studied in pentobarbitone-anesthetized cats. Intravenous administration of spiroperidol, haloperidol, perphenazine and chlorpromazine increased resting ventilation, the intensity and duration of the effect being ...
ZAPATA, P, ZUAZO, A
openaire +2 more sources
Charged analogs of chlorpromazine as dopamine antagonists
Journal of Medicinal Chemistry, 1987Chlorpromazine (1, CPZ) is a potent dopamine antagonist that has been used widely as an antipsychotic agent. Since dopaminergic antagonists, like dopaminergic agonists, exist in solution as the charged and uncharged molecular species, it is not clear which form of the amine is most important for interaction with the dopamine receptor.
M W, Harrold +6 more
openaire +2 more sources

